Mitchell L. Krassan
2014
In 2014, Mitchell L. Krassan earned a total compensation of $438.5K as Executive Vice President and Chief Strategy Officer at TherapeuticsMD, a 95% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $15,000 |
---|---|
Option Awards | $197,917 |
Salary | $213,200 |
Other | $12,379 |
Total | $438,496 |
Krassan received $213.2K in salary, accounting for 49% of the total pay in 2014.
Krassan also received $15K in non-equity incentive plan, $197.9K in option awards and $12.4K in other compensation.
Rankings
In 2014, Mitchell L. Krassan's compensation ranked 10,715th out of 13,032 executives tracked by ExecPay. In other words, Krassan earned more than 17.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,715 out of 13,032 | 18th |
Division Manufacturing | 4,083 out of 4,966 | 18th |
Major group Chemicals And Allied Products | 1,404 out of 1,686 | 17th |
Industry group Drugs | 1,125 out of 1,365 | 18th |
Industry Pharmaceutical Preparations | 858 out of 1,043 | 18th |
Source: SEC filing on April 25, 2017.
Krassan's colleagues
We found four more compensation records of executives who worked with Mitchell L. Krassan at TherapeuticsMD in 2014.